SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

New CRO Helomics partners up on prostate cancer liquid biopsies

16-Jan-2017 - Helomics has signed a deal with the diagnostics firm MDNA Life Sciences Inc., to help further develop MDNA’s liquid biopsy platform and commercialize its tests for prostate cancer.

Certara updates population-based simulator

12-Jan-2017 - The updated Simcyp Simulator features several enhanced models to help predict pharmacokinetic outcomes in virtual patient populations.

Pharmaron acquires Xceleron as it looks to provide 'end-to-end' services

11-Jan-2017 - Pharmaron’s acquisition of Xceleron further supports early discovery, preclinical and clinical development with expanded radiolabeled sciences capabilities.

UPDATED

'I am Not Dead Yet' target earns Berlin virtual biotech a deal with Evotec

10-Jan-2017 - Following an €8M Series A fundraising round by Eternygen GmBh, the German CRO Evotec AG will help get the virtual biotech’s metabolic disease inhibitor programme to preclinical trials. 

Strategic partnership forms single-source solution for biopharma

10-Jan-2017 - CSSi LifeSciences and BioMARC have announced a strategic partnership to provide 'fully cohesive product development and support' for vaccine and biologic development. 

Drug discovery collaboration could lead to a long-term clinical development effort

09-Jan-2017 - Sharp Edge Labs will use its propriety biosensor platform to identify lead compounds for Sumitomo Dainippon Pharma – technology that the company says will help focus discussions on outcomes rather...

Pfizer licenses cell lines from preclinical CRO, Absorption Systems

05-Jan-2017 - Absorption Systems has announced a technology licensing agreement with Pfizer Inc., in which the pharma company will use the preclinical CRO’s cell lines to test potential drug candidates.

Bruker buys mAb and immunoassay supplier InVivo

05-Jan-2017 - Bruker has bolstered its molecular biologics and mass spectrometric offering through the acquisition of contract manufacturing organisation (CMO) InVivo Biotech.

CrownBio expands into Louisiana primate research center with $1m facility

04-Jan-2017 - Crown Bioscience will invest $1m into a new subsidiary in Louisiana state to work alongside a new research facility at the New Iberia Research Center (NIRC).

Synpromics to develop synthetic promotors for GE’s CHO platform

04-Jan-2017 - GE Healthcare hopes to increase the yield of biopharmaceuticals made using its Chinese Hamster Ovary (CHO) expression system through a partnership with synthetic biology firm Synpromics.

Aptuit to conduct integrated discovery project as part of new agreement

04-Jan-2017 - Aptuit and Chiesi Farmaceutici have introduced an integrated discovery project to identify novel compounds to treat Idiopathic Pulmonary Fibrosis.

Pfizer turns to Charles Stark Draper Laboratory for 'organ-on-a-chip' tech

22-Dec-2016 - The Charles Stark Draper Laboratory Inc. has inked a three year partnership with Pfizer to create personalised versions of Draper’s Microphysiological Systems (MPS), for cheaper and more effective preclinical testing....

BioCity CRO creates new Bioanalysis space with Thermo Scientific

20-Dec-2016 - XenoGesis has upgraded its spectroscopy capabilities in a deal with Thermo Fisher Scientific Inc. 

Domainex is first UK CRO to invest in NanoTemper’s novel Drug Discovery technology

19-Dec-2016 - NanoTemper Technologies Gmbh has scored custom from the UK CRO Domainex Ltd., which is using its MicroScale Thermophoresis technology for speedier, “higher quality clinical candidates”.

News in brief

Maryland CRO gets thumbs up in animal testing checkup

15-Dec-2016 - Smithers Avanza is granted renewal of full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), with “no recommendation for improvements.”

News in brief

Evotec completes Cyprotex acquisition

15-Dec-2016 - Evotec AG has completed its previously announced acquisition of the preclinical contract research organization (CRO), Cyrotex.

Eurofins Genomics launches EXTREmers

14-Dec-2016 - Eurofins Genomics has launched its EXTREmer oligonucleotides in the US – adding another ‘tool’ to help researchers advance drug discovery.

Startup forges ‘Superbug Alliance’ with Evotec to engineer new antibiotics

13-Dec-2016 - Evotec AG and Forge Therapeutics Inc have entered a two-year agreement to discover novel antibiotics for Gram-negative bacterial infections, including resistant strains.

Purdue Pharma enters new therapeutic area with Exicure collaboration

13-Dec-2016 - Through the collaboration, Purdue will leverage Exicure’s Spherical Nucleic Acid (SNA)™ technology to discover and develop a treatment for psoriasis, and other diseases.

38 dead: Animal Welfare Institute criticises ‘Weak settlement’ in US CRO primate case

12-Dec-2016 - The Institute claims SNBL USA has committed dozens of violations to the Animal Welfare Act and demands more severe consequences from the US Department of Agriculture.

MilliporeSigma to speed up production of Acticor’s antibody against stroke

07-Dec-2016 - Acticor Biotech has made a deal with Merck KGaA’s CMO MilliporeSigma to use its Provantage End-to-End services to make its anti-thrombotic antibody fragment ACT-017 for stroke.

CRISPR/Cas9 transforming research, says Charles River CSO

06-Dec-2016 - Charles River Laboratories has announced an "end-to-end" service offering of CRISPR/Cas9 genome engineering technology, including custom in vivo and in vitro genome editing.

Machine learning answers 'holy grail' questions to accelerate drug development

06-Dec-2016 - Celgene  has made a second investment in a machine learning and simulation platform for applications across drug discovery, clinical development, and commercialization.

Primate breeding CRO Alpha Genesis investing $2m into SC site

05-Dec-2016 - Alpha Genesis, Inc. (AGI) will expand its South Carolina facility and add 30 jobs to support its primate breeding capabilities.

News in brief

Evotec signs on Merck Group to target discovery platform with CRISPR deal

05-Dec-2016 - Merck KGaA has partnered up with clinical research organisation (CRO) Evotec Ag to serve as a one-stop shop for new target discovery using its gene-editing reagents.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...